Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid

Jordon, 1967, Basement zone antibodies in bullous pemphigoid, JAMA, 200, 751, 10.1001/jama.200.9.751

Arbesman, 1974, IgE levels in sera of patients with pemphigus or bullous pemphigoid, Arch Dermatol, 110, 378, 10.1001/archderm.110.3.378

Delaporte, 1996, IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid, J Immunol, 157, 3642, 10.4049/jimmunol.157.8.3642

Mutasim, 1985, A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex, J Invest Dermatol, 84, 47, 10.1111/1523-1747.ep12274684

Labib, 1986, Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting, J Immunol, 136, 1231, 10.4049/jimmunol.136.4.1231

Stanley, 1988, Isolation of complementary DNA for bullous pemphigoid antigen by use of patients’ autoantibodies, J Clin Invest, 82, 1864, 10.1172/JCI113803

Diaz, 1990, Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome, J Clin Invest, 86, 1088, 10.1172/JCI114812

Giudice, 1992, Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180, J Invest Dermatol, 99, 243, 10.1111/1523-1747.ep12616580

Giudice, 1993, Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain, J Immunol, 151, 5742, 10.4049/jimmunol.151.10.5742

Van den Bergh, 2003, BP180 (type XVII collagen) and its role in cutaneous biology and disease, Adv Dermatol, 19, 37

Liu, 1993, A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180, J Clin Invest, 92, 2480, 10.1172/JCI116856

Liu, 1995, Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid, J Immunol, 155, 5449, 10.4049/jimmunol.155.11.5449

Haase, 1998, Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2, J Invest Dermatol, 110, 282, 10.1046/j.1523-1747.1998.00126.x

Schmidt, 2000, Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid, Arch Dermatol, 136, 174, 10.1001/archderm.136.2.174

Zillikens, 1997, Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies, J Invest Dermatol, 109, 573, 10.1111/1523-1747.ep12337492

Ruhrberg, 1997, The plakin family: versatile organizers of cytoskeletal architecture, Curr Opin Genet Dev, 7, 392, 10.1016/S0959-437X(97)80154-2

Guo, 1995, Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration, Cell, 81, 233, 10.1016/0092-8674(95)90333-X

Borradori, 1999, Structure and function of hemidesmosomes: more than simple adhesion complexes, J Invest Dermatol, 112, 411, 10.1046/j.1523-1747.1999.00546.x

Kiss, 2005, Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230, J Autoimmun, 24, 1, 10.1016/j.jaut.2004.09.007

Nishie, 2007, Humanization of autoantigen, Nat Med, 13, 378, 10.1038/nm1496

Liu, 1995, The role of complement in experimental bullous pemphigoid, J Clin Invest, 95, 1539, 10.1172/JCI117826

Liu, 1997, A major role for neutrophils in experimental bullous pemphigoid, J Clin Invest, 100, 1256, 10.1172/JCI119639

Liu, 1998, Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid, J Exp Med, 188, 475, 10.1084/jem.188.3.475

Liu, 2000, A critical role for neutrophil elastase in experimental bullous pemphigoid, J Clin Invest, 105, 113, 10.1172/JCI3693

Nelson, 2006, Role of different pathways of the complement cascade in experimental bullous pemphigoid, J Clin Invest, 116, 2892, 10.1172/JCI17891

Provost, 1974, Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin, Clin Exp Immunol, 18, 193

Dopp, 2000, IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity, J Am Acad Dermatol, 42, 577, 10.1016/S0190-9622(00)90168-3

Dimson, 2003, Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid, J Invest Dermatol, 120, 784, 10.1046/j.1523-1747.2003.12146.x

Parodi, 1992, Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid, Br J Dermatol, 126, 526, 10.1111/j.1365-2133.1992.tb11833.x

Soh, 1993, IgE and its related phenomena in bullous pemphigoid, Br J Dermatol, 128, 371, 10.1111/j.1365-2133.1993.tb00193.x

Fairley, 2005, Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid, J Invest Dermatol, 125, 467, 10.1111/j.0022-202X.2005.23853.x

Ghohestani, 1998, IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230), J Clin Immunol, 18, 202, 10.1023/A:1020531005776

Zillikens, 1997, A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid, J Invest Dermatol, 109, 679, 10.1111/1523-1747.ep12338088

Tsuji-Abe, 2005, Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid, J Dermatol Sci, 37, 145, 10.1016/j.jdermsci.2004.10.007

Hamada, 2001, Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule, Exp Dermatol, 10, 256, 10.1034/j.1600-0625.2001.100405.x

Hall, 1993, Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid, J Invest Dermatol, 101, 9, 10.1111/1523-1747.ep12358276

Capron, 1984, Role of IgE receptors in effector function of human eosinophils, J Immunol, 132, 462, 10.4049/jimmunol.132.1.462

Gounni, 1994, The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy?, J Allergy Clin Immunol, 94, 1214, 10.1016/0091-6749(94)90334-4

Frossi, 2004, The mast cell: an antenna of the microenvironment that directs the immune response, J Leukoc Biol, 75, 579, 10.1189/jlb.0603275

Nagpal, 1990, Demonstration of IgE antibodies to nucleic acid antigens in patients with SLE, Autoimmunity, 8, 59, 10.3109/08916939008998433

Burastero, 1993, Rheumatoid arthritis with monoclonal IgE rheumatoid factor, J Rheumatol, 20, 489

Raikow, 1992, Correlation of serum immunoglobulin E elevations with clinical stages of dysthyroid orbitopathy, Ophthalmology, 99, 361, 10.1016/S0161-6420(92)31964-5

Guo, 1997, Thyroid peroxidase autoantibodies of IgE class in thyroid autoimmunity, Clin Immunol Immunopathol, 82, 157, 10.1006/clin.1996.4297

Sato, 1999, A possible role of immunoglobulin E in patients with hyperthyroid Graves’ disease, J Clin Endocrinol Metab, 84, 3602, 10.1210/jc.84.10.3602

Hirano, 2007, IgE(b) immune complexes activate macrophages through Fcgamma RIV binding, Nat Immunol, 8, 762, 10.1038/ni1477

Liu, 2004, Bullous pemphigoid: using animal models to study the immunopathology, J Investig Dermatol Symp Proc, 9, 41, 10.1111/j.1087-0024.2004.00841.x

Tomassini, 1991, Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation, J Allergy Clin Immunol, 88, 365, 10.1016/0091-6749(91)90099-A

Khalife, 1986, Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils, J Immunol, 137, 1659, 10.4049/jimmunol.137.5.1659